Nano-curcumin for Clinical Symptoms and Gastrointestinal Inflammation in Children with Celiac Disease: A Pilot Randomized Controlled Trial Protocol

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 23

فایل این مقاله در 18 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_INJPM-14-8_005

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Background: Celiac disease (CD) is a chronic, systemic immune-mediated condition triggered by gluten exposure in genetically predisposed individuals and characterized by intestinal inflammation, mucosal injury, and impaired nutrient absorption. Lifelong adherence to a strict gluten-free diet remains the cornerstone of treatment, yet inflammatory and gastrointestinal manifestations may persist despite dietary adherence. Curcumin has anti-inflammatory and antioxidant properties and may modulate T-cell activation, antigen-presenting cell function, inflammatory signaling, oxidative stress, intestinal barrier integrity, and gut microbial balance. This pilot randomized controlled trial was designed to investigate whether adjunctive nano-curcumin can improve disease-related clinical manifestations and inflammatory biomarkers in children with CD.Methods: This prospective, single-center, double-blind, placebo-controlled, parallel-group pilot trial will be conducted at Akbar Children's Hospital, Mashhad, Iran. Thirty eligible children aged ۵–۱۸ years with celiac disease of less than six months' duration will be randomly allocated in a ۱:۱ ratio to nano-curcumin (۸۰ mg/day) or matched placebo for ۱۲ weeks while receiving a gluten-free diet. The two primary outcomes are changes from baseline to week ۱۲ in fecal calprotectin and serum tissue transglutaminase IgA (tTG-IgA). Secondary outcomes are gastrointestinal symptoms measured by the Gastrointestinal Symptom Rating Scale (GSRS) and standardized anthropometric measures. The primary analysis will use baseline-adjusted analysis of covariance (ANCOVA); logarithmic transformation will be considered for markedly right-skewed positive biomarker values. Because this is an exploratory pilot trial, the study is not powered to provide definitive evidence of efficacy.Conclusion: This pilot trial will evaluate the feasibility and preliminary effects of adjunctive nano-curcumin on gastrointestinal symptoms and inflammatory and serological outcomes in children with newly diagnosed CD receiving a gluten-free diet. The study is intended to generate preliminary estimates of treatment effects and outcome variability rather than establish definitive clinical efficacy. Its findings may provide an empirical basis for the design of a subsequent adequately powered randomized controlled trial.Trial registration: Iranian Registry of Clinical Trials IRCT۲۰۲۴۰۷۲۱۰۶۲۵۰۱N۱. Registered on October ۱۹, ۲۰۲۴.

نویسندگان

- -

Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Department of Clinical Pharmacy, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

- -

Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Caio G, Volta U, Sapone A, Leffler DA, De Giorgio ...
  • Sahin Y. Celiac disease in children: A review of the ...
  • King JA, Jeong J, Underwood FE, Quan J, Panaccione N, ...
  • Sansotta N, Amirikian K, Guandalini S, Jericho H. Celiac disease ...
  • Kårhus LL, Skaaby T, Petersen J, Madsen AL, Thuesen BH, ...
  • Aljada B, Zohni A, El-Matary W. The gluten-free diet for ...
  • Porpora M, Conte M, Lania G, Bellomo C, Rapacciuolo L, ...
  • Mayassi T, Ladell K, Gudjonson H, McLaren JE, Shaw DG, ...
  • Barone MV, Auricchio R, Nanayakkara M, Greco L, Troncone R, ...
  • Rossi RE, Dispinzieri G, Elvevi A, Massironi S. Interaction between ...
  • Ferretti G, Bacchetti T, Masciangelo S, Saturni L. Celiac disease, ...
  • Maluf SW, Wilhelm Filho D, Parisotto EB, Medeiros GD, Pereira ...
  • Moretti S, Mrakic-Sposta S, Roncoroni L, Vezzoli A, Dellanoce C, ...
  • Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, ...
  • Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. ...
  • Villanueva MS, Alimi Y. Microscopic colitis (lymphocytic and collagenous), eosinophilic ...
  • Koskela R. Microscopic colitis: clinical features and gastroduodenal and immunogenetic ...
  • Green PH, Yang J, Cheng J, Lee AR, Harper JW, ...
  • Nimri FM, Muhanna A, Almomani Z, Khazaaleh S, Alomari M, ...
  • Songtanin B, Kahathuduwa C, Nugent K. Fecal calprotectin level in ...
  • Ardelean MV, Kundnani NR, Sharma A, Dumitru M, Buzas R, ...
  • Songtanin B, Evans A, Nugent K, Costilla V. The utility ...
  • Witkin JM, Li X. Curcumin, an active constiuent of the ...
  • Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological ...
  • Zeng L, Yang T, Yang K, Yu G, Li J, ...
  • Haftcheshmeh SM, Mirhafez SR, Abedi M, Heydarlou H, Shakeri A, ...
  • Husby S, Koletzko S, Korponay‐Szabó I, Kurppa K, Mearin ML, ...
  • Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and ...
  • Talebi S, Day AS, Safarian M, Sayedi SJ, Jaafari MR, ...
  • Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the ...
  • Jafari SA, Khalesi M, Kianifar H, Shojaie H, Kiani MA. ...
  • Kliem C, Merling A, Giaisi M, Köhler R, Krammer PH, ...
  • Lin Y, Liu H, Bu L, Chen C, Ye X. ...
  • Ali T, Shakir F, Morton J. Curcumin and inflammatory bowel ...
  • Molaei E, Molaei A, Abedi F, Hayes AW, Karimi G. ...
  • Xu G, Gu Y, Yan N, Li Y, Sun L, ...
  • Gupta KB, Mantha AK, Dhiman M. Mitigation of gliadin-induced inflammation ...
  • Di Meo F, Margarucci S, Galderisi U, Crispi S, Peluso ...
  • Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin and ...
  • Liu X, Zhu H. [Retracted] Curcumin Improved Intestinal Epithelial Barrier ...
  • Huang J, Guan B, Lin L, Wang Y. Improvement of ...
  • Zam W. Gut microbiota as a prospective therapeutic target for ...
  • Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. The effect ...
  • Ben-Horin S, Salomon N, Karampekos G, Viazis N, Lahat A, ...
  • Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, ...
  • نمایش کامل مراجع